Dissecting GPCR Contributions to Gαo-Dependent Motor Dysfunction in GNAO1-Related Disorders Using Caenorhabditis...

Area of Science:

• Neuroscience
• Genetics
• Pharmacology

Background:

• Pathogenic variants in GNAO1 lead to severe neurodevelopmental disorders.
• G protein subunit Gαo is crucial for transducing inhibitory signals from G protein-coupled receptors (GPCRs) involved in motor control.
• Current pharmacological treatments for GNAO1 disorders are limited.

Purpose of the Study:

• Investigate the role of GPCRs in Gαo-dependent locomotor phenotypes.
• Utilize gene-edited Caenorhabditis elegans models (goa-1 mutants) to study GNAO1 function.
• Identify potential therapeutic targets for GNAO1-related disorders.

Main Methods:

• Pharmacological screening of dopamine and cannabinoid ligands in goa-1 mutants.
• Structural analysis of GPCR ligand-binding pocket conservation.
• Genetic perturbation of receptor function using RNAi and knockout approaches.

Main Results:

• GPCR signaling modulation showed non-linear, context-dependent effects on locomotion.
• Excessive excitatory GPCR input ameliorated hyperactive locomotion in goa-1 mutants.
• Structural conservation of GPCR-ligand binding pockets was necessary but not sufficient for predicting functional responses.

Conclusions:

• Excessive excitatory GPCR input is a key factor in motor dysfunction associated with impaired Gαo signaling.
• C. elegans is a valuable model for dissecting GPCR-mediated signaling in GNAO1 disorders.
• Integrating pharmacological and genetic approaches is crucial for selecting therapeutic targets.